Optimization of Iron Therapy in Hemodialysis Patients Treated with rHuEPO
- 1 July 1994
- journal article
- Published by Wiley in Seminars in Dialysis
- Vol. 7 (4) , 288-292
- https://doi.org/10.1111/j.1525-139x.1994.tb00788.x
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Recombinant ErythropoietinAsaio Journal, 1993
- Recombinant ErythropoietinAsaio Journal, 1993
- Evolution of Recombinant Human Erythropoietin Usage in Clinical Practice in the United StatesAsaio Journal, 1993
- Recombinant Human Erythropoietin Reduces Free Erythrocyte Protoporphyrin Levels in Patients on Chronic DialysisNephron, 1992
- RACTICAL GUIDELINES FOR DRUG THERAPY IN DIALYSIS George R. Aronoff, Series Editor: Iron Dextran in Chronic Renal FailureSeminars in Dialysis, 1991
- Iron status in patients receiving erythropoietin for dialysis-associated anemiaKidney International, 1989
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- Iron Balance in Hemodialysis PatientsAnnals of Internal Medicine, 1977
- The Treatment of Iron Deficiency Anaemia by Iron-Dextran Infusion: A Radio-Isotope StudyBritish Journal of Haematology, 1968
- Metabolism of 59Fe-Dextran Complex in Human SubjectsBMJ, 1957